
Company Info
Phone(412) 206-5303
Year Established
2019
Ticker
TSXV
Exchange
SHRX
Contacts
Scott Sneddon, PhD, JDCEO & CSO
Company Description
Combining high-speed experimentation and modern computational methods with the accelerated clinical development path available in gCombining high-speed experimentation and modern computational methods with the accelerated clinical development path available in genetic disease.enetic disease.
